Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A generous gift of £3.3million from the entrepreneur, private investor and philanthropist Mr André Hoffmann has secured the future of an Oxford Chair in Developmental Medicine.

Professor Georg Holländer, an expert in developmental biology and Head of the Department of Paediatrics at Oxford, currently holds the Chair. With this support, Professor Holländer will be able to advance our knowledge of how cells of the immune system grow and differentiate during foetal development and early life, resulting in the normal formation of our tissues and organs. This knowledge is vital in underpinning regenerative medicine, an area of scientific study that promises to transform patient care in the 21st century by reactivating cells to restore function after injury or disease.

Read the full story 

Similar stories

Celebrating Early Careers Researchers on International Women's Day

General

In these short interviews, Anna Kordala and Jane Millar talk about the research they do at the Department of Paediatrics.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

COVID-19 Research Vaccinology

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

Oxford vaccine effective against major B.1.1.7 ‘Kent’ coronavirus strain circulating in the UK

COVID-19 Research Vaccinology

A preprint of ongoing work to assess effectiveness of Oxford’s ChAdOx1 coronavirus vaccine shows that the existing vaccine has similar efficacy against the B.1.1.7 ‘Kent’ coronavirus strain currently circulating in the UK to previously circulating variants.

Children’s pain ‘swept under the carpet for too long’ – Lancet Commission

Neuroimaging Publication Research

The launch of Lancet Child and Adolescent Health Commission - the first ever to address paediatric pain - aims to raise the profile of children’s pain from early years to early adulthood.

Coronavirus: is it safe for children to return to school?

COVID-19 Children's Health General Parents & Carers

Stéphane Paulus and Else Bijker explore the topic in their article for The Conversation.

Oxford COVID-19 vaccine begins human trial stage

COVID-19 Recruitment Research Vaccinology

University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford today. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half (the control group) receiving a widely available meningitis vaccine.